Roivant Sciences ROIV Income Statement
| TTM Q4 '25 | TTM Q3 '25 | TTM Q2 '25 | TTM Q1 '25 | TTM Q4 '24 | ||
|---|---|---|---|---|---|---|
| $4.01M+137% | -$11.4M+40.6% | -$22.56M-58.2% | -$18.32M-27.7% | -$10.72M-74.6% | ||
| —— | -$809.24M-2,446% | -$373.97M-108% | -$490.63M-110% | -$171.98M-104% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- What is Roivant Sciences's revenue?
- Roivant Sciences (ROIV) generated $8.3M in revenue over the trailing twelve months, down 71.6% year over year.
- Where does Roivant Sciences's income statement data come from?
- Every line is extracted from Roivant Sciences's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
